Hepatitis C News

Asian patients with hepatocellular carcinoma had the lowest waitlist dropout rates and highest 5-year survival after liver transplantation before and after the policy change, while Black or African American patients had the worst outcomes.

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, spoke with Healio about a presentation from The Liver Meeting on “The Toronto Protocol,” an ultra-short course of glecaprevir/pibrentasvir with ezetimibe.

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses findings from an abstract at The Liver Meeting, which estimated the prevalence of hepatitis C virus infection in the United States between 2017 and 2020.

BOSTON — Healio spoke with Norah Terrault, MD, MPH, FAASLD, about presentations from The Liver Meeting that investigated testing and treatment of hepatitis C virus infection among pregnant individuals.

A test-and-treat model for hepatitis C virus infection among injection drug users and people experiencing homelessness resulted in high levels of treatment initiation, completion and cure, and may expand care access to marginalized groups.

BOSTON — In this video, Tatyana Kushner, MD, MSCE, spoke with Healio about interim results from a study investigating treatment of hepatitis c virus infection in pregnant people.

BOSTON — Tatyana Kushner, MD, MSCE, spoke with Healio about rapid testing options for hepatitis C virus to improve the cascade of care.

BOSTON — In this video, Tatyana Kushner, MD, MSCE, discusses the “significant focus” at The Liver Meeting on the elimination of hepatitis C virus.

BOSTON — In this video, John W. Ward, MD, discusses strategies to drive the elimination of hepatitis C virus, including commitment on a national scale.

BOSTON — In this video, John W. Ward, MD, discusses multiple presentations at The Liver Meeting that focused on testing and treatment for hepatitis C virus infection.